Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading of pharmaceutical products like medicines, injections and other related products. The Company's product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, liquid injection, and pharma products. It offers products for anti-infective, respiratory system, gynecology, cardio and CNS (central nervous system), antibacterial, anti-diabetic, and anti-malaria. The Company serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia, and 26 states across India. The Company's products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms), and Tinnex Capsule used to treat tinnitus.
Lincoln Pharmaceuticals Ltd FAQs
How to Buy Lincoln Pharmaceuticals Ltd Share?
To purchase Lincoln Pharmaceuticals Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Lincoln Pharmaceuticals Ltd (ticker symbol: LINCOLN) on the trading platform provided by your broker and purchase the shares.
What's Lincoln Pharmaceuticals Ltd share price today?
The stock price of Lincoln Pharmaceuticals Ltd as of 07 Oct 2025 is ₹520.38
What is the Market Cap of Lincoln Pharmaceuticals Ltd?
Market capitalisation represents the total market value of a company's outstanding shares. As of 07 Oct 2025, Lincoln Pharmaceuticals Ltd (ticker symbol: LINCOLN) has a market capitalisation of approximately ₹10,70,00,00,000.00
What is the PE and PB ratio of Lincoln Pharmaceuticals Ltd?
Lincoln Pharmaceuticals Ltd Ltd's price-to-book ratio as of 07 Oct 2025 is 1.55, reflecting the market's valuation compared to its asset value. As of 07 Oct 2025, the trailing twelve months P/E (price-to-earnings) ratio is 12.66, indicating the market values the company at around ₹12.66 for every ₹1 of earnings
What is the 52 Week High and Low of Lincoln Pharmaceuticals Ltd Share?
Lincoln Pharmaceuticals Ltd Ltd (LINCOLN) hit its 52-week high at ₹979.50, and its 52-week low at ₹499.00.